AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32128718 — intervention group
Group type: EXPERIMENTAL
Intervention: After once artificial abortion (AOAA)
Number of subjects: 254
Study 32128718 — intervention group
Group type: EXPERIMENTAL
Intervention: After twice artificial abortion (ATAA)
Number of subjects: 254
Study 32128718 — intervention group
Group type: EXPERIMENTAL
Intervention: After three times or more artificial abortion (ATTMAA)
Number of subjects: 254
Study 32128718 — intervention group
Group type: COMPARATOR
Intervention: Normal control group (NC)
Number of subjects: 254
Study 36482733 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Stimulation Therapy (CST)
Number of subjects: 47
Study 36482733 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 47
Study 34930841 — intervention group
Group type: EXPERIMENTAL
Intervention: Emails from ostensibly Black senders
Number of subjects: 250000
Study 34930841 — intervention group
Group type: COMPARATOR
Intervention: Emails from ostensibly White senders
Number of subjects: 250000
Study 34431186 — intervention group
Group type: EXPERIMENTAL
Intervention: Barostat-assisted sensory training (BAST)
Number of subjects: 66
Study 34431186 — intervention group
Group type: COMPARATOR
Intervention: Syringe-assisted sensory training (SAST)
Number of subjects: 66
Study 33298154 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine, antivirals, and analgesics
Number of subjects: 750
Study 33298154 — intervention group
Group type: COMPARATOR
Intervention: Control (antivirals and analgesics only)
Number of subjects: 750
Study 33298154 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 750
Study 34344428 — intervention group
Group type: EXPERIMENTAL
Intervention: Culture‐directed antibacterial therapy based on percutaneous bone biopsy culture results
Number of subjects: 80
Study 34344428 — intervention group
Group type: COMPARATOR
Intervention: Culture‐directed antibacterial therapy based on ulcer bed biopsy culture results
Number of subjects: 80
Study 32367393 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple airway maneuver
Number of subjects: 103
Study 32367393 — intervention group
Group type: COMPARATOR
Intervention: Standard technique
Number of subjects: 103
Study 32091293 — intervention group
Group type: EXPERIMENTAL
Intervention: Video livestream from a smartphone during telephone-assisted CPR
Number of subjects: 46
Study 33860324 — intervention group
Group type: EXPERIMENTAL
Intervention: SNP selection strategy using a combination of mean minor allele frequency (MAF) and linkage disequilibrium (LD)
Number of subjects: 1135
Study 33860324 — intervention group
Group type: COMPARATOR
Intervention: Random SNP selection
Number of subjects: 1135
Study 33860324 — intervention group
Group type: EXPERIMENTAL
Intervention: SNP categorized as low MAF (0.01 < MAF ≤ 0.1)
Number of subjects: 1135
Study 33860324 — intervention group
Group type: EXPERIMENTAL
Intervention: SNP located on autosomal extremes
Number of subjects: 1135
Study 33860324 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotyping panel consisting of 10,000 SNP selected based on breed-specific selection criteria
Number of subjects: 1135
Study 33992256 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) applied using a cluster device (Laser + LED), three times a week for four weeks.
Number of subjects: 30
Study 33992256 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 30
Study 33248591 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated transport at -10°C uncontrolled RH
Number of subjects: 540
Study 33248591 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated transport at +30°C 30%RH
Number of subjects: 540
Study 33248591 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated transport at +30°C 80%RH
Number of subjects: 540
Study 33248591 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated transport at +21°C 30%RH
Number of subjects: 540
Study 33248591 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated transport at +21°C 80%RH
Number of subjects: 540
Study 33248591 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated transport at +30°C 30%RH for prolonged duration
Number of subjects: 540
Study 33248591 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated transport at -10°C for prolonged duration
Number of subjects: 540
Study 35354620 — intervention group
Group type: EXPERIMENTAL
Intervention: Decentering training for 5 weeks
Number of subjects: 57
Study 35354620 — intervention group
Group type: COMPARATOR
Intervention: Active control group (light physical exercise and cognitive training)
Number of subjects: 57
Study 33609457 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination at birth
Number of subjects: 560
Study 33609457 — intervention group
Group type: COMPARATOR
Intervention: Delayed BCG vaccination (at age 6 weeks)
Number of subjects: 560
Study 32132639 — intervention group
Group type: EXPERIMENTAL
Intervention: Video intervention designed to demonstrate the consequences of disadvantageous choices
Number of subjects: 60
Study 32132639 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 60
Study 34319268 — intervention group
Group type: EXPERIMENTAL
Intervention: Manikin-based simulation training
Number of subjects: 0
Study 34319268 — intervention group
Group type: COMPARATOR
Intervention: Case discussion
Number of subjects: 0
Study 34132690 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg daily
Number of subjects: 36
Study 34132690 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin 100 mg daily
Number of subjects: 36
Study 35420254 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Perclose device
Number of subjects: 506
Study 35420254 — intervention group
Group type: COMPARATOR
Intervention: Double Perclose device
Number of subjects: 506
Study 33533320 — intervention group
Group type: EXPERIMENTAL
Intervention: HFCS-sweetened soft drink
Number of subjects: 12
Study 33533320 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose-sweetened soft drink
Number of subjects: 12
Study 33533320 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 12
Study 34890214 — intervention group
Group type: EXPERIMENTAL
Intervention: AC-THP (Taxane + Trastuzumab + Pertuzumab)
Number of subjects: 1846
Study 34890214 — intervention group
Group type: COMPARATOR
Intervention: AC-KP (Trastuzumab Emtansine + Pertuzumab)
Number of subjects: 1846
Study 34890214 — intervention group
Group type: EXPERIMENTAL
Intervention: AC-THP
Number of subjects: 1846
Study 34890214 — intervention group
Group type: COMPARATOR
Intervention: AC-KP
Number of subjects: 1846
Study 33243277 — intervention group
Group type: EXPERIMENTAL
Intervention: Double Sequential External Defibrillation (DSED)
Number of subjects: 0
Study 33243277 — intervention group
Group type: EXPERIMENTAL
Intervention: Vector Change (VC) Defibrillation
Number of subjects: 0
Study 33243277 — intervention group
Group type: COMPARATOR
Intervention: Standard Defibrillation
Number of subjects: 0
Study 33243277 — intervention group
Group type: EXPERIMENTAL
Intervention: DSED
Number of subjects: 0
Study 33243277 — intervention group
Group type: EXPERIMENTAL
Intervention: Early DSED (first DSED shock is shock 4–6)
Number of subjects: 0
Study 33243277 — intervention group
Group type: EXPERIMENTAL
Intervention: Late DSED (first DSED shock is shock 7 or later)
Number of subjects: 0
Study 33313768 — intervention group
Group type: EXPERIMENTAL
Intervention: Trophectoderm biopsy
Number of subjects: 756
Study 33313768 — intervention group
Group type: COMPARATOR
Intervention: Unbiopsied blastocysts
Number of subjects: 756
Study 34809506 — intervention group
Group type: EXPERIMENTAL
Intervention: Interrupted every 20 min with 1 min light intensity half squats plus calf raises (EX)
Number of subjects: 20
Study 34809506 — intervention group
Group type: COMPARATOR
Intervention: Uninterrupted sitting (CON)
Number of subjects: 20
Study 33704698 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher doses of exercise training
Number of subjects: 1590
Study 33704698 — intervention group
Group type: COMPARATOR
Intervention: Lower doses of exercise training
Number of subjects: 1590
Study 33020354 — intervention group
Group type: EXPERIMENTAL
Intervention: S One Group I (new instruments)
Number of subjects: 20
Study 33020354 — intervention group
Group type: EXPERIMENTAL
Intervention: S One Group II (used instruments after ex vivo treatment)
Number of subjects: 20
Study 33020354 — intervention group
Group type: COMPARATOR
Intervention: Comparison of Group I and Group II for S One and M-Two
Number of subjects: 20
Study 35274747 — intervention group
Group type: EXPERIMENTAL
Intervention: Incredible Years® Teacher Classroom Management (TCM) programme
Number of subjects: 44
Study 34088381 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component communication intervention on conversations regarding ICD deactivation and advance care planning
Number of subjects: 407
Study 34088381 — intervention group
Group type: COMPARATOR
Intervention: Physician estimated prognosis of < 1 year
Number of subjects: 407
Study 34088381 — intervention group
Group type: COMPARATOR
Intervention: Physician estimated prognosis of > 1 year
Number of subjects: 407
Study 34088381 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall patient-physician prognostic concordance (PPPC)
Number of subjects: 407
Study 36074963 — intervention group
Group type: EXPERIMENTAL
Intervention: 24% Su
Number of subjects: 300
Study 36074963 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% Su
Number of subjects: 300
Study 36074963 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% Su
Number of subjects: 300
Study 36074963 — intervention group
Group type: EXPERIMENTAL
Intervention: LC 15‐min
Number of subjects: 300
Study 36074963 — intervention group
Group type: EXPERIMENTAL
Intervention: LC 30‐min
Number of subjects: 300
Study 36074963 — intervention group
Group type: EXPERIMENTAL
Intervention: LC 45‐min
Number of subjects: 300
Study 36074963 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 24% Su and LC 30 minutes before puncture
Number of subjects: 300
Study 36074963 — intervention group
Group type: COMPARATOR
Intervention: Control group (no analgesia)
Number of subjects: 300
Study 33546737 — intervention group
Group type: EXPERIMENTAL
Intervention: Connect‐Home intervention
Number of subjects: 360
Study 33546737 — intervention group
Group type: COMPARATOR
Intervention: Standard discharge planning
Number of subjects: 360
Study 32403367 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose-based TPN (group G)
Number of subjects: 0
Study 32403367 — intervention group
Group type: COMPARATOR
Intervention: Lipid-based TPN (group L)
Number of subjects: 0
Study 36109546 — intervention group
Group type: EXPERIMENTAL
Intervention: Quiz group (n=26, attractive-type nudges)
Number of subjects: 112
Study 36109546 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intentions group (n=25, social-type nudges)
Number of subjects: 112
Study 36109546 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth mindset group (n=25, timely-type nudges)
Number of subjects: 112
Study 36109546 — intervention group
Group type: COMPARATOR
Intervention: Reference group (n=36, no nudges)
Number of subjects: 112
Study 33994294 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 100
Study 33994294 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide
Number of subjects: 100
Study 33994294 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 100
Study 33994294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 33994294 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 100
Study 33994294 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 100
Study 32248227 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) with home exercise program (HEP)
Number of subjects: 130
Study 32248227 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS) with home exercise program (HEP)
Number of subjects: 130
Study 32248227 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined NMES/TENS with home exercise program (HEP)
Number of subjects: 130
Study 32248227 — intervention group
Group type: COMPARATOR
Intervention: Active home exercise program (HEP) only
Number of subjects: 130
Study 32248227 — intervention group
Group type: EXPERIMENTAL
Intervention: All electrical stimulation groups (NMES, TENS, NMES/TENS)
Number of subjects: 130
Study 32248227 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups (NMES, TENS, NMES/TENS)
Number of subjects: 130
Study 35961180 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored computer program (MAPS)
Number of subjects: 304
Study 35961180 — intervention group
Group type: COMPARATOR
Intervention: Non-tailored control video
Number of subjects: 304
Study 35738655 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-designed health and education model intervention involving regular case-based discussions and paediatric support
Number of subjects: 12
Study 35738655 — intervention group
Group type: COMPARATOR
Intervention: Control group (half of the schools)
Number of subjects: 12
Study 32697484 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human soluble thrombomodulin (0.06 mg/kg/d; n = 395)
Number of subjects: 800
Study 32697484 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 405)
Number of subjects: 800
Study 32697484 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human soluble thrombomodulin
Number of subjects: 800
Study 35392841 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.02% atropine
Number of subjects: 400
Study 35392841 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% atropine
Number of subjects: 400
Study 35392841 — intervention group
Group type: COMPARATOR
Intervention: Control (SV spectacles only)
Number of subjects: 400
Study 36317342 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical fixation with Kirschner wire
Number of subjects: 0
Study 36317342 — intervention group
Group type: COMPARATOR
Intervention: Moulded casting
Number of subjects: 0
Study 33910230 — intervention group
Group type: EXPERIMENTAL
Intervention: Less-intensive therapies
Number of subjects: 1987
Study 33910230 — intervention group
Group type: COMPARATOR
Intervention: Intensive therapies
Number of subjects: 1987
Study 35038337 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-to-moderate intensity physical education class (LIPE)
Number of subjects: 120
Study 35038337 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined group (PLUS)
Number of subjects: 120
Study 35038337 — intervention group
Group type: EXPERIMENTAL
Intervention: High‐intensity physical education class (HIPE)
Number of subjects: 120
Study 35038337 — intervention group
Group type: COMPARATOR
Intervention: Standard physical education lessons (CTRL)
Number of subjects: 120
Study 34585137 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile app-based training for health literacy, 8 weeks duration, content read once a week
Number of subjects: 140
Study 34585137 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 140
Study 36334223 — intervention group
Group type: EXPERIMENTAL
Intervention: Celery seed extract (1.34 g per day)
Number of subjects: 50
Study 35725254 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO-CST (Caregiver Skills Training)
Number of subjects: 130
Study 35725254 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 130
Study 32180692 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish group receiving fatty fish three times per week
Number of subjects: 81
Study 32180692 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving an alternative meal (e.g. chicken, pork, and beef)
Number of subjects: 81
Study 35894881 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated functional core and plyometric training program (CPT) for 8 weeks
Number of subjects: 44
Study 35894881 — intervention group
Group type: COMPARATOR
Intervention: Usual training sessions
Number of subjects: 44
Study 33349280 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for insomnia (CBT-I); 8 sessions
Number of subjects: 0
Study 33349280 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture; 10 sessions
Number of subjects: 0
Study 34405412 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured lipids (SLs) obtained from chemical interesterification (CIE) of blends with 60-70% wt. palm kernel stearin (PKS)
Number of subjects: 0
Study 34405412 — intervention group
Group type: COMPARATOR
Intervention: Physical blends (PBs) of palm kernel stearin, coconut oil, and fully hydrogenated palm stearin
Number of subjects: 0
Study 34405412 — intervention group
Group type: COMPARATOR
Intervention: Cocoa butter alternatives (CBAs)
Number of subjects: 0
Study 34102947 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal prehabilitation
Number of subjects: 3
Study 34102947 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3
Study 34102947 — intervention group
Group type: EXPERIMENTAL
Intervention: Normo Prehab
Number of subjects: 3
Study 32198306 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer reviewers receive a reminder and short explanation of the 10 most important and poorly reported CONSORT items; they check if these items are reported in the submitted manuscript.
Number of subjects: 166
Study 32198306 — intervention group
Group type: COMPARATOR
Intervention: Usual journal practice (control group).
Number of subjects: 166
Study 36327271 — intervention group
Group type: EXPERIMENTAL
Intervention: Larviciding intervention in urban areas
Number of subjects: 26
Study 36327271 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention areas
Number of subjects: 26
Study 33730722 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginseng (twice daily for 4 weeks)
Number of subjects: 60
Study 33730722 — intervention group
Group type: COMPARATOR
Intervention: Placebo (twice daily for 4 weeks)
Number of subjects: 60
Study 35726506 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Isotretinoin
Number of subjects: 75
Study 35726506 — intervention group
Group type: EXPERIMENTAL
Intervention: Acitretin
Number of subjects: 75
Study 35726506 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 32554534 — intervention group
Group type: EXPERIMENTAL
Intervention: ARD-3150 (inhaled liposomal ciprofloxacin)
Number of subjects: 0
Study 33310418 — intervention group
Group type: EXPERIMENTAL
Intervention: eculizumab (1200 mg/2 weeks)
Number of subjects: 143
Study 33310418 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 143
Study 33310418 — intervention group
Group type: EXPERIMENTAL
Intervention: eculizumab
Number of subjects: 143
Study 32305398 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon-expandable (BE) valve
Number of subjects: 241
Study 32305398 — intervention group
Group type: COMPARATOR
Intervention: Self-expanding (SE) valve
Number of subjects: 241
Study 36254415 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple technique
Number of subjects: 114
Study 36254415 — intervention group
Group type: COMPARATOR
Intervention: Classical technique
Number of subjects: 114
Study 32460799 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally-adapted minimal-guidance online self-help program (8-week 'Selge' online program)
Number of subjects: 600
Study 32460799 — intervention group
Group type: COMPARATOR
Intervention: Control condition (self-administered test of alcohol use and advice regarding usual treatment in Estonia)
Number of subjects: 600
Study 35590348 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person CETA delivery
Number of subjects: 0
Study 35590348 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth-delivered CETA (T-CETA)
Number of subjects: 0
Study 35590348 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study 35590348 — intervention group
Group type: EXPERIMENTAL
Intervention: CETA
Number of subjects: 0
Study 35590348 — intervention group
Group type: EXPERIMENTAL
Intervention: T-CETA
Number of subjects: 0
Study 35590348 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary outcomes
Number of subjects: 0
Study 33663538 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher resilience scores
Number of subjects: 575
Study 34424995 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloid-based priming solution (dextran 40)
Number of subjects: 84
Study 34424995 — intervention group
Group type: COMPARATOR
Intervention: Crystalloid-based priming solution (Ringer-Acetate plus mannitol)
Number of subjects: 84
Study 34424995 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 84
Study 33854007 — intervention group
Group type: EXPERIMENTAL
Intervention: UIC201609/UIC201610 (combination of rabeprazole and CR mosapride)
Number of subjects: 30
Study 33854007 — intervention group
Group type: COMPARATOR
Intervention: rabeprazole 10 mg once a day
Number of subjects: 30
Study 33854007 — intervention group
Group type: COMPARATOR
Intervention: mosapride 15 mg CR tablet once a day
Number of subjects: 30
Study 34674209 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide slurry
Number of subjects: 111
Study 34674209 — intervention group
Group type: COMPARATOR
Intervention: Swallowed fluticasone multidose inhaler
Number of subjects: 111
Study 34662498 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic apixaban
Number of subjects: 574
Study 34662498 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 574
Study 33027266 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban health zones
Number of subjects: 515
Study 33027266 — intervention group
Group type: EXPERIMENTAL
Intervention: Savannah landscape
Number of subjects: 515
Study 33027266 — intervention group
Group type: COMPARATOR
Intervention: Climate types
Number of subjects: 515
Study 33027266 — intervention group
Group type: COMPARATOR
Intervention: Health zones
Number of subjects: 515
Study 33027266 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetation types
Number of subjects: 515
Study 35727536 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab 70 mg
Number of subjects: 25
Study 35727536 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab 140 mg
Number of subjects: 25
Study 35727536 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab (both doses)
Number of subjects: 25
Study 33463426 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine (EPN) irrigation solution (0.33 mg per 1 L of saline)
Number of subjects: 90
Study 33463426 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) irrigation solution (0.42 mg per 1 L of saline)
Number of subjects: 90